Patient safety should be the No. 1 consideration for healthcare organizations working, planning or hoping to adopt AI. Then again, nine other concerns are similarly crucial to the success of the industry-wide endeavor.

This partnership reflects NextGen Healthcare’s deepening commitment to supporting cardiology practices nationwide. Research shows that nearly 50 percent of adults in the United States have some form of cardiovascular disease today—a rate expected to grow to 61 percent by 2050.

No industry has taken cybercrime on the chin more than healthcare over the past 13 years. That trend continues in 2024, as global data breaches cost healthcare $9.77 million between March 2023 and February 2024.

Prior authorization is frustrating to clinicians, but a new survey from the American Medical Association shows it also frustrates patients to the point of abandoning care. The survey showed many more insights regarding PA impact on care.

Here’s a factoid you may not have seen coming. By 2030, the six countries of the Gulf Cooperation Council annually purchase more than $23 billion worth of products and services related to generative AI.

Compounded semaglutide injectable products are at the heart of these concerns. While the FDA says compounded drugs “can serve an important medical need for patients,” the agency does not approve these new formulations, increasing the risk of complications. 

A North Korean national who may or may not still reside in his home country has been indicted for allegedly leading ransomware attacks against U.S. hospitals.

Calling the legislation the Hospital Stability and Health Services Act, Sen. Tammy Baldwin (D-Wis.) suggests she wrote the bill with rural communities in mind.